Envestnet Asset Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-78,879
| Closed | -$592K | – | 4087 |
|
2022
Q2 | $592K | Buy |
78,879
+35,423
| +82% | +$266K | ﹤0.01% | 2969 |
|
2022
Q1 | $395K | Buy |
43,456
+5,988
| +16% | +$54.4K | ﹤0.01% | 3269 |
|
2021
Q4 | $263K | Sell |
37,468
-45,292
| -55% | -$318K | ﹤0.01% | 3490 |
|
2021
Q3 | $943K | Buy |
82,760
+16,423
| +25% | +$187K | ﹤0.01% | 2589 |
|
2021
Q2 | $1.06M | Sell |
66,337
-4,102
| -6% | -$65.7K | ﹤0.01% | 2487 |
|
2021
Q1 | $1.26M | Buy |
70,439
+7,461
| +12% | +$133K | ﹤0.01% | 2229 |
|
2020
Q4 | $851K | Buy |
62,978
+8,723
| +16% | +$118K | ﹤0.01% | 2327 |
|
2020
Q3 | $639K | Buy |
54,255
+24,790
| +84% | +$292K | ﹤0.01% | 2332 |
|
2020
Q2 | $435K | Buy |
29,465
+15,673
| +114% | +$231K | ﹤0.01% | 2490 |
|
2020
Q1 | $186K | Buy |
13,792
+4,416
| +47% | +$59.6K | ﹤0.01% | 2753 |
|
2019
Q4 | $227K | Buy |
+9,376
| New | +$227K | ﹤0.01% | 2871 |
|
2017
Q3 | – | Sell |
-414
| Closed | -$22K | – | 3081 |
|
2017
Q2 | $22K | Hold |
414
| – | – | ﹤0.01% | 2583 |
|
2017
Q1 | $19K | Hold |
414
| – | – | ﹤0.01% | 2678 |
|
2016
Q4 | $16K | Buy |
+414
| New | +$16K | ﹤0.01% | 2702 |
|